Are you curious about where the best low-density lipoprotein (LDL) cholesterol products come from? In a world where heart health is paramount, understanding the top factories in China can make a significant difference in your choices. By comparing these leading manufacturers, you can ensure that you’re selecting high-quality products that support your well-being. Imagine having the confidence that comes from knowing you’re making informed decisions for your health. Dive into our article to discover the top LDL cholesterol factories in China and find out which options stand out for quality and reliability!

Low-Density Lipoprotein Cholesterol, CVD Risk, and Mortality in China

Product Details: Verification service for human users on jamanetwork.com

Technical Parameters:
– Security review process
– Connection validation

Application Scenarios:
– Website access control
– User verification for online services

Pros:
– Enhances security
– Prevents automated access

Cons:
– May cause delays
– User inconvenience during verification

Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and …

Product Details: Study on the association between low-density lipoprotein cholesterol (LDL-C) and mortality in different atherosclerotic cardiovascular disease (ASCVD) risk groups in China.

Technical Parameters:
– Participants aged 35 to 75 years
– Data collected from National Mortality Surveillance System

Application Scenarios:
– Assessing cardiovascular disease risk
– Guiding lipid control targets in clinical practice

Pros:
– Large sample size of 4,379,252 individuals
– Identifies optimal LDL-C levels for different ASCVD risk profiles

Cons:
– Limited evidence for specific LDL-C targets in diverse populations
– Potential confounding factors not fully addressed

Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and …

Product Details: This study examines the association between low-density lipoprotein cholesterol (LDL-C) levels and mortality in patients with different atherosclerotic cardiovascular disease (ASCVD) risk stratifications.

Technical Parameters:
– Cohort study involving 3,789,025 participants
– Median LDL-C concentration of 93.1 mg/dL

Application Scenarios:
– Lipid management strategies for individuals with varying ASCVD risk levels
– Clinical practice for cardiovascular disease prevention

Pros:
– Identifies U-shaped and J-shaped associations between LDL-C and mortality
– Suggests tailored lipid management strategies based on ASCVD risk

Cons:
– Limited evidence for low-ASCVD-risk populations
– Potential for reverse causality in associations

Low-density lipoprotein cholesterol and all-cause mortality: findings …

Product Details: Study on the relationship between low-density lipoprotein cholesterol (LDL-C) and all-cause mortality among middle-aged and elderly Chinese population.

Technical Parameters:
– Participants: 4981 male and 5529 female respondents
– Follow-up duration: 4 years

Application Scenarios:
– Epidemiological studies on cholesterol levels and mortality
– Public health assessments in aging populations

Pros:
– Provides insights into LDL-C levels and mortality risk
– Highlights potential harmful effects of low LDL-C levels

Cons:
– Findings may not be generalizable to other populations
– No significant association found in women

Associations of low-density lipoprotein cholesterol with all-cause and …

Product Details: Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China

Technical Parameters:
– Sample size: 211,290 adults aged 65 or older
– Follow-up duration: 3.08 years

Application Scenarios:
– Epidemiological studies on cholesterol levels and mortality
– Public health recommendations for older adults

Pros:
– Large representative sample size
– Detailed analysis of LDL-C levels and mortality risks

Cons:
– Limited to older adults in China
– Potential confounding factors not fully addressed

Prevalence of dyslipidemia and achievement of low-density lipoprotein …

Product Details: Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.

Technical Parameters:
– Survey conducted on 163,641 adults aged > 18 years in mainland China between 201…
– Measurement of fasting serum total cholesterol (TC), LDL-C, HDL-C, and triglycer…

Application Scenarios:
– Assessment of dyslipidemia prevalence in Chinese adults.
– Evaluation of LDL-C lowering targets and treatment effectiveness.

Pros:
– Provides a comprehensive overview of lipid levels in a large population.
– Highlights the need for improved lipid management and treatment strategies.

Cons:
– Data may not reflect current trends due to the survey being conducted in 2013-20…
– Limited to the Chinese adult population, which may not be generalizable to other…

Achievement of low-density lipoprotein cholesterol targets in Chinese …

Product Details: Ezetimibe in combination with statins for LDL-C lowering in ASCVD patients.

Technical Parameters:
– LDL-C target values: <1.8 mmol/L (Chinese guideline), <1.4 mmol/L (European guid…
– Combination therapy with atorvastatin or rosuvastatin

Application Scenarios:
– Patients with atherosclerotic cardiovascular disease (ASCVD)
– Patients not achieving LDL-C goals with statin therapy alone

Pros:
– Significant reduction in LDL-C levels when combined with statins
– Improved achievement rates of LDL-C targets in certain patient populations

Cons:
– Low overall achievement rates of LDL-C targets in real-world settings
– Underutilization of combination therapy in ASCVD patients

2023 China Guidelines for Lipid Management – PMC – PubMed Central (PMC)

Product Details: 2023 China Guidelines for the Management of Blood Lipids

Technical Parameters:
– LDL-C reduction for every 1 mmol/L reduction in LDL-C, there is a 20% to 23% red…
– Non-HDL-C = TC−HDL-C

Application Scenarios:
– Primary prevention to prevent the occurrence of ASCVD
– Secondary prevention to improve the prognosis of ASCVD

Pros:
– Improved lipid management
– Comprehensive guidance for lipid management across various age groups

Cons:
– Insufficient information to list cons
– Insufficient information to list cons

An equation for calculating small dense low-density lipoprotein cholesterol

Product Details: Equation for calculating small dense low-density lipoprotein cholesterol (sdLDL-C) using standard lipid profile.

Technical Parameters:
– Modified equation: sdLDL-C = 0.14ln(TG)LDL-C – 0.45*LDL-C + 10.88
– Validation set accuracy: 90.47% vs. 89.73% for original equation

Application Scenarios:
– Identifying residual cardiovascular risk in patients
– Estimating sdLDL-C levels in large population studies

Pros:
– More accurate than previous equations for estimating sdLDL-C
– Utilizes standard lipid profile data for broader applicability

Cons:
– Requires specific lipid measurements which may not be available in all settings
– Potential variability in accuracy based on population differences

Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol … – PubMed

Product Details: Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China

Technical Parameters:
– LDL-C measurement
– Statin therapy utilization

Application Scenarios:
– Patients with atherosclerotic cardiovascular disease (ASCVD)
– Patients with diabetes mellitus (DM)

Pros:
– Provides real-world evidence on LDL-C goal achievement
– Highlights treatment patterns in high-risk patients

Cons:
– Relatively low statin use and LDL-C target attainment
– Limited to a specific geographic region (Fuzhou, China)

Related Video

Comparison Table

Company	Product Details	Pros	Cons	Website
Low-Density Lipoprotein Cholesterol, CVD Risk, and Mortality in China	Verification service for human users on jamanetwork.com	– Enhances security – Prevents automated access	– May cause delays – User inconvenience during verification	jamanetwork.com
Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and …	Study on the association between low-density lipoprotein cholesterol (LDL-C) and mortality in different atherosclerotic cardiovascular disease (ASCVD)…	– Large sample size of 4,379,252 individuals – Identifies optimal LDL-C levels for different ASCVD risk profiles	– Limited evidence for specific LDL-C targets in diverse populations – Potential confounding factors not fully addressed	pubmed.ncbi.nlm.nih.gov
Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and …	This study examines the association between low-density lipoprotein cholesterol (LDL-C) levels and mortality in patients with different atheroscleroti…	– Identifies U-shaped and J-shaped associations between LDL-C and mortality – Suggests tailored lipid management strategies based on ASCVD risk	– Limited evidence for low-ASCVD-risk populations – Potential for reverse causality in associations	pmc.ncbi.nlm.nih.gov
Low-density lipoprotein cholesterol and all-cause mortality: findings …	Study on the relationship between low-density lipoprotein cholesterol (LDL-C) and all-cause mortality among middle-aged and elderly Chinese population…	– Provides insights into LDL-C levels and mortality risk – Highlights potential harmful effects of low LDL-C levels	– Findings may not be generalizable to other populations – No significant association found in women	pubmed.ncbi.nlm.nih.gov
Associations of low-density lipoprotein cholesterol with all-cause and …	Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China	– Large representative sample size – Detailed analysis of LDL-C levels and mortality risks	– Limited to older adults in China – Potential confounding factors not fully addressed	pubmed.ncbi.nlm.nih.gov
Prevalence of dyslipidemia and achievement of low-density lipoprotein …	Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163…	– Provides a comprehensive overview of lipid levels in a large population. – Highlights the need for improved lipid management and treatment strategie…	– Data may not reflect current trends due to the survey being conducted in 2013-20… – Limited to the Chinese adult population, which may not be gene…	www.sciencedirect.com
Achievement of low-density lipoprotein cholesterol targets in Chinese …	Ezetimibe in combination with statins for LDL-C lowering in ASCVD patients.	– Significant reduction in LDL-C levels when combined with statins – Improved achievement rates of LDL-C targets in certain patient populations	– Low overall achievement rates of LDL-C targets in real-world settings – Underutilization of combination therapy in ASCVD patients	www.ncbi.nlm.nih.gov
2023 China Guidelines for Lipid Management – PMC – PubMed Central (PMC)	2023 China Guidelines for the Management of Blood Lipids	– Improved lipid management – Comprehensive guidance for lipid management across various age groups	– Insufficient information to list cons – Insufficient information to list cons	pmc.ncbi.nlm.nih.gov
An equation for calculating small dense low-density lipoprotein cholesterol	Equation for calculating small dense low-density lipoprotein cholesterol (sdLDL-C) using standard lipid profile.	– More accurate than previous equations for estimating sdLDL-C – Utilizes standard lipid profile data for broader applicability	– Requires specific lipid measurements which may not be available in all settings – Potential variability in accuracy based on population differences	lipidworld.biomedcentral.com
Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol … – PubMed	Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China	– Provides real-world evidence on LDL-C goal achievement – Highlights treatment patterns in high-risk patients	– Relatively low statin use and LDL-C target attainment – Limited to a specific geographic region (Fuzhou, China)	pubmed.ncbi.nlm.nih.gov

Frequently Asked Questions (FAQs)

What is low density lipoprotein (LDL) cholesterol?

LDL cholesterol is often referred to as “bad” cholesterol because high levels can lead to plaque buildup in your arteries, increasing the risk of heart disease and stroke. It carries cholesterol from the liver to the cells, but when there’s too much, it can cause health issues.

Why are LDL cholesterol factories important in China?

These factories play a crucial role in producing medications and supplements that help manage cholesterol levels. With rising health concerns, they contribute to improving public health by providing effective treatments for cholesterol-related conditions.

How does LDL cholesterol affect my health?

High levels of LDL cholesterol can lead to serious health problems, including heart disease, heart attacks, and strokes. It’s essential to monitor your cholesterol levels and maintain a healthy lifestyle to keep your LDL in check.

What measures are taken to ensure the quality of LDL cholesterol products in China?

Factories in China adhere to strict regulations and quality control measures to ensure the safety and efficacy of their products. This includes rigorous testing and compliance with international standards to provide reliable medications and supplements.

Can I lower my LDL cholesterol without medication?

Yes, you can lower your LDL cholesterol through lifestyle changes. Eating a heart-healthy diet, exercising regularly, maintaining a healthy weight, and avoiding tobacco can significantly improve your cholesterol levels and overall heart health.